Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary bacterial and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the APC Microbiome Institute based at University College Cork, Ireland.
An international business, AH is centred on targeting health indications and exploiting applications arising from its core bacterial strains and derivatives via:
- Basic and applied research into novel applications
- Research partnerships in applications for Food, Food Supplement, Medical Food and Rx products
- Marketing of a range of proprietary brands for the clinical and consumer markets
AH's mission is to develop clinically supported microbiome based healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of unique bacterial strains and their actives for inflammatory and infectious conditions, reflecting our expertise in gastrointestinal medicine, the brain-gut axis, metabolic health and nutrition.
Since 1999, approximately 150 peer reviewed publications on AH’s strains have been published, many of which have been influential in understanding the beneficial nature of the relationship between bacteria and the human digestive system. In fact, two key scientific papers detailing the clinical work of AH’s lead 35624™ strain of Bifidobacterium infantis in Irritable Bowel Syndrome have been cited more than 1,000 times in scientific literature since their publication.